Attend a nearby educational event about AMVUTTRA® (vutrisiran)

Upcoming events

Patient Educational Event

Jamaica, New York

September 02, 2026 | 5:00 PM-7:00 PM ET

Hear from an Alnylam Patient Education Liaison, Christopher, joined by Patient Ambassador, John, treated with AMVUTTRA, and Olakunle Akinboboye, a healthcare professional.

Register

Patient Educational Event

Garden City, New York

September 09, 2026 | 6:00 PM-8:00 PM ET

Hear from an Alnylam Patient Education Liaison, Christopher, joined by Patient Ambassador, Gary, treated with AMVUTTRA, and Shaline Rao, a healthcare professional.

Register

Patient Educational Event

Virtual Program

September 22, 2026 | 3:00 PM-4:30 PM ET

Hear from an Alnylam Patient Education Liaison, Teresa, joined by Patient Ambassador, Kelly, treated with AMVUTTRA, and Elaine Perkins, a healthcare professional.

Register

Patient Educational Event

Palm Springs, California

September 23, 2026 | 12:00 PM-1:30 PM PT

Hear from an Alnylam Patient Education Liaison, Rita, joined by Patient Ambassador, Tim, treated with AMVUTTRA, and Elizabeth Hushka, a healthcare professional.

Register

Patient Educational Event

Indianapolis, Indiana

September 30, 2026 | 6:00 PM-7:30 PM ET

Hear from an Alnylam Patient Education Liaison, Kathy, joined by Patient Ambassador, Steve, treated with AMVUTTRA, and Elaine Perkins, a healthcare professional.

Register

Patient Educational Event

Lansing, Michigan

October 08, 2026 | 6:00 PM-7:30 PM ET

Hear from an Alnylam Patient Education Liaison, Kathy, joined by Patient Ambassador, Tom, treated with AMVUTTRA, and Elizabeth Hushka, a healthcare professional.

Register

Patient Educational Event

Southfield, Michigan

October 14, 2026 | 6:00 PM-8:00 PM ET

Hear from an Alnylam Patient Education Liaison, Kathy, joined by Patient Ambassador, Ed, treated with AMVUTTRA, and Penny, their spouse and caregiver, and Elaine Perkins, a healthcare professional.

Register

Patient Educational Event

Poughkeepsie, New York

October 21, 2026 | 6:00 PM-8:00 PM ET

Hear from an Alnylam Patient Education Liaison, Kathleen, joined by Patient Ambassador, Gary, treated with AMVUTTRA, and Naveen Bellam, a healthcare professional.

Register

Patient Educational Event

Metairie, Louisiana

October 28, 2026 | 5:30 PM-7:00 PM CT

Hear from an Alnylam Patient Education Liaison, Diane, joined by Patient Ambassador, Al, treated with AMVUTTRA, and Deborah, their spouse and caregiver, and Chris Michael Bell, a healthcare professional.

Register

Patient Educational Event

Rancho Cucamonga, California

October 29, 2026 | 12:00 PM-1:30 PM PT

Hear from an Alnylam Patient Education Liaison, Rita, joined by Patient Ambassador, Paul, treated with AMVUTTRA, and Elizabeth Hushka, a healthcare professional.

Register

Patient Educational Event

Jacksonville, Florida

October 29, 2026 | 6:00 PM-8:00 PM ET

Hear from an Alnylam Patient Education Liaison, Teresa, joined by Patient Ambassador, Mike, treated with AMVUTTRA, and Chris Michael Bell, a healthcare professional.

Register

Patient Educational Event

Frederick, Maryland

November 11, 2026 | 6:00 PM-8:00 PM ET

Hear from an Alnylam Patient Education Liaison, Rachel, joined by Patient Ambassador, Art, treated with AMVUTTRA, and Albert Hicks, a healthcare professional.

Register

Important Safety Information

What are the most important things I should know about AMVUTTRA® (vutrisiran)?

AMVUTTRA can cause low vitamin A levels

Treatment with AMVUTTRA lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking AMVUTTRA, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of AMVUTTRA?

The most common side effects of AMVUTTRA were pain in the arms or legs, pain in the joints, shortness of breath, and low vitamin A levels.

These are not all the possible side effects of AMVUTTRA. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA). Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.

For additional information about AMVUTTRA, please see the full Prescribing Information.

Indications

What is AMVUTTRA?

AMVUTTRA is a prescription medicine that treats the:

  • cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce heart-related death, hospital stays and urgent visits.
  • polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.